Nanoplastics (NPs, <100 nm) have emerged as nano-scale contaminants with superior mobility and biological barrier-crossing capacity, yet risk assessment fails due to unstandardized analytical methods and a lack of realistic exposure data. This perspective proposes an “Exposome–Microbiome–Immune” (EMI) framework as a One Health paradigm to integrate detection, toxicokinetics, and systemic effects. We prioritize the following actions: (i) validated nano–Fourier transform infrared spectroscopy (nanoFTIR) and surface-enhanced Raman spectroscopy (SERS) for environmental/human monitoring; (ii) multigenerational studies in zebrafish and organoids; (iii) longitudinal cohorts for biomonitoring. Without shifting from descriptive reviews to systems toxicology, NP risk will remain underestimated.
Building similarity graph...
Analyzing shared references across papers
Loading...
José Alberto Gonçalves
João Pequeno
Davor Kržišnik
Pollutants
University of Ljubljana
Universidade Nova de Lisboa
Building similarity graph...
Analyzing shared references across papers
Loading...
Gonçalves et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69d895be6c1944d70ce06e59 — DOI: https://doi.org/10.3390/pollutants6020021
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: